NEW YORK – Artificial intelligence company Nucleai and Jefferson Health on Tuesday announced a collaboration to discover histological biomarkers that predict response to immunotherapy. Tel Aviv-based Nucleai will use its ATOM platform to...

Register Now AIRA Matrix invites you to a symposium on the development and validation of Deep Learning algorithms for the detection and quantification of the major features of Progressive Cardiomyopathy (PCM) in rodents.  Rodent PCM...

WESTBURY, N.Y. —  BioIVT’s ASTERAND® Human Tissue Repository contains clinical data from more than one million biospecimens and can be mined to reveal patterns and relationships in disease etiology and pathology. BioIVT, a leading...

MOUNTAIN VIEW, Calif., Sept. 10, 2021 -- Crosscope, a leading AI software provider in digital pathology is collaborating with NINGBO KONFOONG BIOINFORMATION TECH CO.,LTD. (KFBIO) an innovative high-tech cutting edge Whole slide imaging...

Swifter discovery can improve life expectancy A longer life expectancy goes hand in hand with the risk of cancer. The Hamburg-based Mindpeak is developing artificial intelligence to help pathologists diagnose cancer swiftly. Until now,...

Enabling high-throughput analysis with deep learning September 16, 2021 | 6:30am – 7:30am EST | 12:30 – 13:30 CEST You're invited to join our virtual presentation, Enabling high-throughput analysis with deep learning on 16 September...